Advertisement

Continuous Coverage of COVID-19


Advertisement
Get Permission

The staff of The ASCO Post recognizes the steady flow of news on the novel coronavirus, or COVID-19. Here, we've compiled a list of links to articles and resources on the COVID-19 pandemic. If you have a report you'd like to share, please e-mail it to us at editor@ascopost.com.

Direct From ASCO: COVID-19 Resources for Oncology Professionals

ASCO has developed and compiled resources to support oncology professionals during the COVID-19 pandemic. Resources include evidence-based answers to Frequently Asked Questions (FAQs) about clinical care of patients with cancer, a centralized collection of links to credible sources, the latest decisions about impacted ASCO meetings and programs, and oncologist-vetted information for patients. This page will be updated regularly as the COVID-19 public health situation evolves.

Ongoing

Coronavirus: What People With Cancer Should Know (via National Cancer Institute)

Coronavirus 2019: What People With Cancer Need to Know (via Cancer.Net)

Johns Hopkins Coronavirus Resource Center (via Johns Hopkins)

COVID-19 Response Tools (via Seattle Cancer Care Alliance)

Coronavirus Disease 2019 (COVID-19) (via FDA.gov)

Telemedicine Amid COVID-19 (via AMA Physician Innovation Network)

March 27

The Blind Leading the Blind: COVID-19, Cancer, and the Need for More Data (via ascopost.com, reprinted from ASCO Daily News)

American College of Surgeons Issues COVID-19 Guidelines for Triage of Patients Undergoing Cancer Surgery (via ascopost.com)

ACCC Mobilizes to Support Delivery of Quality Cancer Care During COVID-19 Pandemic (via the Association of Community Cancer Centers)

Giuseppe Curigliano, MD, PhD, on How COVID-19 Is Affecting Cancer Care: The View From Italy

FDA Takes Action to Help Increase U.S. Supply of Ventilators and Respirators for Protection of Health Care Workers, Patients (via FDA.gov)

March 26

Practicing Oncology in the Era of COVID-19 (via ascopost.com)

Association for Clinical Oncology: More Testing, Personal Protective Equipment, Practice Support Needed During COVID-19 Crisis (via ascopost.com)

Karen E. Knudsen, PhD, MBA, on Delivering Cancer Care During the COVID-19 Pandemic: Report From Philadelphia

How Should Radiation Oncologists Manage Prostate Cancer Patients During the COVID-19 Pandemic? (via Michigan Health Lab)

March 25

U.S. Should Open Visas to International Physicians Amid COVID-19 (via AMA)

U.S. Companies, Labs Rush to Produce Blood Test for Coronavirus Immunity (via Reuters)

AMA, APHA, ASHP Issue Joint Statement About COVID-19 Medications (via AMA)

MIPS Reporting Deadline Extended to April 30 Due to COVID-19 (via ASCO in Action)

IASLC Statement on Coronavirus Disease 2020 (via IASLC)

Cancer Drug Trials on Hold Amid Coronavirus Disruption (via Nature)

March 24

Update on 2020 ASCO Annual Meeting (via ASCO)

Oncologists on the Front Lines of COVID‑19: A Conversation With John Cole, MD (via ascopost.com)

A Message From the FDA OCE for Patients With Cancer and Health-Care Providers on COVID-19 (via ascopost.com)

FDA Takes Action to Increase U.S. Supplies Through Instructions for PPE and Device Manufacturers (via FDA.gov)

When Might Experimental Drugs to Treat Covid-19 Be Ready? A Forecast (via STAT)

United States Could Become Coronavirus Epicenter: WHO (via Reuters)

AMA, AHA, ANA: #StayHome to Confront COVID-19 (via AMA)

Some Cancer Patients Face Delayed Surgeries and Scaled-Back Treatments as the Coronavirus Advances (via Washington Post)

FDA Expedites Treatment Of Seriously Ill COVID-19 Patients With Experimental Plasma (via NPR)

March 23

As Covid-19 Spreads, Disruptions to Clinical Trial and Drug Development Accelerate (via STAT)

Fair Allocation of Scarce Medical Resources in the Time of Covid-19 (via The New England Journal of Medicine)

March 22

Scientists Identify 69 Drugs to Test Against the Coronavirus (via The New York Times)

CMS Announces Relief for Clinicians, Providers, Hospitals and Facilities Participating in Quality Reporting Programs in Response to COVID-19 (via CMS.gov)

When Cancer And Coronavirus Collide: Fear And Resilience (via NPR)

March 21

Coronavirus (COVID-19) Update: FDA Issues First Emergency Use Authorization for Point of Care Diagnostic (via FDA.gov)

March 20

Managing Cancer Care During the COVID-19 Pandemic (via ascopost.com)

Common Questions About Coronavirus 2019 and Cancer: Answers for Patients and Survivors (via Cancer.Net)

Coronavirus Lockdown: What I Learnt When I Shut My Cancer Lab in 48 Hours (via nature.com)

MD Anderson Implements Restrictions Due to 2019 Novel Coronavirus Disease (COVID-19) (via MD Anderson)

The Dilemmas Facing Cancer Doctors and Patients in the Coronavirus Pandemic (via Vox)

AMA Resources Available to Physicians to Navigate COVID-19 Pandemic (via American Medical Association)

Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic (via FDA.gov)

FDA Guidance on Conduct of Clinical Trials of Medical Products During COVID-19 Pandemic (via ascopost.com)

The One-Two Punch: Cancer And Coronavirus (via Forbes)

CCC19 Registry Launched to Understand COVID-19 in Patients With Cancer (via Cancer Network)

Why the Coronavirus Has Been So Successful (via The Atlantic)

March 19

COVID-19 May Remain Stable for Hours to Days in Aerosols and on Surfaces (via ascopost.com)

Podcast: Coronavirus, Patients With Cancer, and the Preparedness of the Institutions That Care for Them (via ascopost.com)

The World Health Organization has launched a global SOLIDARITY clinical trial to study treatments for COVID-19. To date, Argentina, Bahrain, Canada, France, Iran, Norway, South Africa, Spain, Switzerland, and Thailand are participating in the trial, and other countries are expected to join in this effort. The drugs being tested in the study include the antiviral drug remdesivir; a combination of two HIV drugs, lopinavir and ritonavir; lopinavir and ritonavir plus interferon beta; and the antimalarial drug chloroquine. (via who.int)

Coronavirus (COVID-19) Update: Blood Donations (via FDA.gov)

Not Business as Usual: COVID-19 Anxiety in the World of Cancer (via ASCO Connection)

March 18

COVID-19 Infection in Patients With Cancer in China (via ascopost.com)

Spring 2020 ABIM Maintenance of Certification Exams Canceled (via abim.org)

COVID-19: Guidance for ASCs on Necessary Surgeries (via Ambulatory Surgery Center Association)

Coronavirus (COVID-19) Update: FDA Issues Guidance for Conducting Clinical Trials (via FDA.gov)

March 17

Mitigating the Spread of COVID-19 and Its Impact on Cancer (via ascopost.com)

How COVID-19 Is Affecting the Oncology Community (via ascopost.com)

Strategies for Protecting Patients and Health-Care Providers Against COVID-19 (via ascopost.com)

ASCO to Hold COVID-19 Webinar for Members (via ASCO in Action)

Oxford University Provide Evidence for Coronavirus Mobile App for Instant Contact Tracing (via medsci.ox.ac.uk)

The Treatment of Patients With Cancer and Containment of COVID-19: Experiences From Italy (via ASCO Daily News)

March 16

Statement From the Ambulatory Surgery Center Association Regarding Elective Surgery and COVID-19 (via ASCA)

March 14

The Coronavirus Is Forcing Hospitals to Cancel Surgeries (via The New York Times)

March 13

Podcast: Pulmonary Pathology of the Novel Coronavirus in Two Patients With Lung Cancer (via ascopost.com)

March 12

COVID-19: Older Patients With Cancer Especially Vulnerable (via Medscape)

March 9

Former FDA Commissioner Scott Gottlieb, MD, Relays Opinions on Coronavirus (via ascopost.com)

March 5

Pulmonary Pathology of Early COVID-19 Pneumonia Identified Retrospectively in Two Patients With Lung Cancer (via ascopost.com)

NCCN Postpones 2020 Annual Conference, Citing Precautions Against Potential Patient Exposure to COVID-19 (via ascopost.com)

The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.
Advertisement

Advertisement



Advertisement